Osteoporosis Drugs Market Growth Rate, Trends, Size, Industry Trends And Forecast To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Osteoporosis Drugs Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $14.2 billion In 2028 At A CAGR Of 3.3% :
The osteoporosis drugs market size has grown steadily in recent years. It will grow from $12 billion in 2023 to $12.48 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to aging population, increased awareness and diagnosis, lifestyle factors, government initiatives and healthcare policies.

The osteoporosis drugs market size is expected to see steady growth in the next few years. It will grow to $14.2 billion in 2028 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to continued aging population trends, advancements in treatment options, increased focus on men's bone health, patient education and empowerment, global health policies and insurance coverage. Major trends in the forecast period include personalized medicine approaches, exploration of combination therapies, focus on fracture prevention strategies, R&D investment in novel drug targets, collaborations for drug development.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp

Osteoporosis Drugs Market Major Segments
The osteoporosis drugs market covered in this report is segmented -
1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors
2) By Administration: Oral, Injectable
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales
4) By Application: Primary Osteoporosis, Secondary Osteoporosis

Key Driver - Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market

A surge in the prevalence of osteoporosis is expected to propel the growth of the osteoporosis drug market. Osteoporosis is a bone disease that occurs when bone mineral density and mass bone decline or when bone quality or structure changes. People who have a low calcium intake are more likely to develop osteoporosis. These osteoporosis drugs increase bone mineral density and help to prevent fractures. For instance, In May 2022, according to statistics published by Amgen, a US-based biotechnology company, states that every year, osteoporosis causes roughly 1.5 million fractures in the United States, resulting in $19 billion in associated costs. Furthermore, the annual number of fractures caused by osteoporosis is expected to rise by 68% from 2018 to 2040, i.e., from 1.9 million to 3.2 million. Therefore, the surging prevalence of osteoporosis is driving the growth of the osteoporosis drugs market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=9102&type=smp

Prominent Trend - Innovative Solutions In Osteoporosis Treatment With Teriparatide Injectable For Affordable And Convenient Patient Care

Major companies operating in the osteoporosis drugs market are advancing toward the use of innovative solutions for the osteoporosis drug market. For instance, in November 2023, Apotex Inc., a Canada-based pharmaceutical corporation, launched Teriparatide Injectable for Osteoporosis Treatment. Injection of teriparatide is a pre-filled pen containing 250 mcg/mL, capable of administering 28 daily doses of 20 mcg per pen, intended for single-patient use. This product will give these patients much-needed, reasonably priced access.

Osteoporosis Drugs Market Players
Major companies operating in the osteoporosis drugs market report are Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Pharma Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd, Mylan N.V., Daiichi Sankyo Company Limited, Union Chimique Belge, Sun Pharmaceutical Industries Ltd., Ipsen, Kyowa Kirin Co Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Recordati S.p.A., Cadila Healthcare Ltd., Lupin Limited, Enzene Biosciences Ltd, Torrent Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Ligand Pharmaceuticals Incorporated, Theramex, Radius Health Inc., Actavis PLC, Strides Pharma Science Limited, Apotex Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the osteoporosis market in 2023. The regions covered in the osteoporosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Osteoporosis Drugs Market Report Structure
3. Osteoporosis Drugs Market Trends And Strategies
4. Osteoporosis Drugs Market - Macro Economic Scenario
5. Osteoporosis Drugs Market Size And Growth
…..
27. Osteoporosis Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.